Suncoast Equity Management Regeneron Pharmaceuticals, Inc. Transaction History

Suncoast Equity Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$543.48 - $670.97 $22.5 Million - $27.8 Million	-41,487 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$574.03 - $680.96 $1.44 Million - $1.71 Million	-2,513 Reduced 5.71%	41,487 $25.1 Million
Q2 2021 Jul 29, 2021	SELL	$472.8 - $558.54 $208,032 - $245,757	-440 Reduced 0.99%	44,000 $24.6 Million
Q1 2021 May 06, 2021	BUY	$446.73 - $548.2 $6.09 Million - $7.48 Million	13,642 Added 44.3%	44,440 $21 Million
Q4 2020 Feb 09, 2021	BUY	$478.3 - $607.98 $14.7 Million - $18.7 Million	30,798 New	30,798 $14.9 Million

1,426

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Suncoast Equity Management, based on Form 13F filings with the SEC.

Stay updated on Suncoast Equity Management with notifications on news.